These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Carbochromen in therapy of acute and chronic coronary insufficiency]. Votcal BE; Lozinskij LG Arzneimittelforschung; 1970 Mar; 20():459-60. PubMed ID: 4989254 [No Abstract] [Full Text] [Related]
3. [Results of a clinical study of the therapeutic effect of intensain in chronic coronary insufficiency]. Shkhvatsabaia IK; Miasnikov LA; Metelitsa VI; Grigor'iants RA Kardiologiia; 1969 Feb; 9(2):66-70. PubMed ID: 4895292 [No Abstract] [Full Text] [Related]
4. [Results of clinical testing of carbochromen in chronic coronary insufficiency]. Schvacabaja IK; Mjasnikov LA; Metelica VI; Grigorjanc RA Arzneimittelforschung; 1970 Mar; 20():449-51. PubMed ID: 4916579 [No Abstract] [Full Text] [Related]
5. Effects of coronary vasodilators on coronary circulation in the sclerotic heart disease. Ito Y; Kojima Y; Hasegawa Y; Sasamoto S; Kishii T; Kobayashi T Jpn Heart J; 1966 Nov; 7(6):524-35. PubMed ID: 5298462 [No Abstract] [Full Text] [Related]
6. Effect of tolamolol versus propranolol on cardiovascular haemodynamics in patients with angina. Aronow WS; March H; Vangrow JS; Cassidy J; Kern JC; Khemka M; Vawter M; Pagano J Br Heart J; 1974 Nov; 36(11):1078-81. PubMed ID: 4155953 [No Abstract] [Full Text] [Related]
7. [Clinical effect and hemodynamic changes during the use of Inderal]. Miasnikov LA; Krasnikov IuA; Nikolaeva EN; Grigor'iants RA Kardiologiia; 1967 Oct; 7(10):67-72. PubMed ID: 5607201 [No Abstract] [Full Text] [Related]
8. Hemodynamic and therapeutic effect of BAY a 1040 on the patients with ischemic heart disease. Hayase S; Hirakawa S; Hosokawa S; Mori N; Kanyama S Arzneimittelforschung; 1972 Feb; 22(2):370-3. PubMed ID: 4554632 [No Abstract] [Full Text] [Related]
9. The haemodynamic effects of prenylamine lactate. Rosenbaum M; Lennon P; Horvath T Med J Aust; 1971 May; 1(20):1053-6. PubMed ID: 5556989 [No Abstract] [Full Text] [Related]
11. [Current problems in the medical treatment of coronary insufficiency]. Cunescu V; Pîrvu V Med Interna (Bucur); 1968 Aug; 20(8):899-905. PubMed ID: 4975788 [No Abstract] [Full Text] [Related]
12. [Clinical experiences with the use of carbochromen in coronary syndrome]. Ivancić R; Persić T; Custović F Arzneimittelforschung; 1970 Mar; 20():454-6. PubMed ID: 4916580 [No Abstract] [Full Text] [Related]
14. Once daily administration of sustained release propranolol capsules in the treatment of angina pectoris. Halkin H; Vered I; Saginer A; Rabinowitz B Eur J Clin Pharmacol; 1979; 16(6):387-91. PubMed ID: 393520 [No Abstract] [Full Text] [Related]
15. [Double-blind clinical trial of a new coronary-active drug, MD 6753]. Dalla Volta S Minerva Cardioangiol; 1974 Oct; 22(10):683-90. PubMed ID: 4215049 [No Abstract] [Full Text] [Related]
16. Therapy of angina pectoris with propranolol and long-acting nitrates. Goldbarg AN; Moran JF; Butterfield TK; Nemickas R; Bermudez GA Circulation; 1969 Dec; 40(6):847-53. PubMed ID: 4988122 [No Abstract] [Full Text] [Related]
17. [Coronary dilators]. Ilic-Vukotić M Med Arh; 1972; 26(2):81-4. PubMed ID: 4402269 [No Abstract] [Full Text] [Related]
18. [Therapy of ischemic heart diseases with carbochromen]. Savenkov PM; Arsukuni RO; Pflug C Arzneimittelforschung; 1970 Mar; 20():461-2. PubMed ID: 5468731 [No Abstract] [Full Text] [Related]
19. Systemic and coronary hemodynamic effects of perhexiline. Rowe GG; Spring DA; Afonso S Arch Int Pharmacodyn Ther; 1970 Oct; 187(2):377-93. PubMed ID: 4921275 [No Abstract] [Full Text] [Related]
20. Proceedings: Influence of perhexiline on the effort tolerance test in angina pectoris. Comparison with placebo and prenylamine. Cherchi A; Bina M; Fonzo R; Raffo M Postgrad Med J; 1973 Apr; 49():Suppl 3:67-74. PubMed ID: 4587035 [No Abstract] [Full Text] [Related] [Next] [New Search]